Expression of functional markers in acute lymphoblastic leukemia

Leukemia Research

Volumn 27, Issue 10, 2003, Pages 903-908

  Oh, Eun Jee ^a   Kahng, Jimin ^a   Kim, Yonggoo ^a   Kim, Myungshin ^a   Lim, Jihyang ^a   Kang, Chang Suk ^a   Min, Woo Sung ^a   Cho, Bin ^a   Lee, Ahwon ^a   Lee, Kyo Young ^a   Kim, Won Il ^a   Shim, Sang In ^a   Han, Kyungja ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Adhesion molecules; Cell cycle; CSF receptor; Functional marker; Lymphoblastic leukemia; MDR

Indexed keywords

CD18 ANTIGEN; DNA TOPOISOMERASE (ATP HYDROLYSING); GELATINASE A; GLYCOPROTEIN P; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HERMES ANTIGEN; KI 67 ANTIGEN; LUNG RESISTANCE PROTEIN; MEMBRANE ANTIGEN; MULTIDRUG RESISTANCE PROTEIN; TUMOR MARKER; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANALYSIS; ARTICLE; CELL CYCLE PARAMETERS; CELL INFILTRATION; CHILD; CONTROLLED STUDY; DEVICE; DISEASE ASSOCIATION; FEMALE; HEPATOSPLENOMEGALY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 0038691763     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00026-2     Document Type: Article

References (31)

1. Han K., Kahng J., Kim M., Lim J., Kim Y., Cho B.et al. Expression of functional markers in acute nonlymphoblastic leukemia. Acta Haematol. 104:2000;174-180.
2. Kartner N., Riordan J.R., Ling V. Cell surface P-glycoprotein is associated with multidrug-resistance in mammalian cells. Science. 221:1983;1285-1288.
3. Gottesman M.M. How cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 53:1993;747-754.
4. Nussler V., Pelka-Fleischer R., Zwierzina H., Nerl C., Beckert B., Gieseler F.et al. P-glycoprotein expression in patients with acute leukemia-clinical relevance. Leukemia. 10:1996;S23-S31.
5. Yau L., Li D., Tsao J., Kuo T., Savaraj N., Lu K. Expression of P-glycoprotein (MDR1) gene in patients with leukemia. Blood. 72:1988;186-189.
6. Loe D.W., Deeley R.G., Cole S.P. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer. 326:1996;945-957.
7. Kool M., de Haas M., Scheffer G.L., Scheper R.J., van Eijk M.J., Juijn J.A.et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57:1997;3537-3547.
8. Bevilacqua M.P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11:1993;767-804.
9. Reuss-Borst M.A., Ning Y., Klein G., Muller C.A. The vascular cell adhesion molecule (VCAM-1) is expressed on a subset of lymphoid and myeloid leukaemias. Br. J. Haematol. 89:1995;299-305.
10. Mielcarek M., Sperling C., Schrappe M., Meyer U., Riehm H., Ludwig W.D. Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukaemia: correlation with clinical features and outcome. Br. J. Haematol. 96:1997;301-307.
11. Hara J., Matsuda Y., Fujisaki H., Tokimasa S., Ohta H., Osagi Y.et al. Expression of adhesion molecules in childhood B-lineage-cell neoplasms. Int. J. Hematol. 72:2000;69-73.
12. Archimbaud E., Thomas X., Campos L., Magaud J.P., Dore J.F., Fiere D. Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis. Leukemia. 6:1992;265-271.
13. Kawada H., Fukuda R., Yoshida M., Takei M., Kobayashi N., Masumoto A.et al. Clinical significance of LEA-1 expression in adult acute myeloid leukemia. Leuk. Res. 20:1996;327-332.
14. Bettelheim P., Valent P., Andreeff M., Tafuri A., Haimi J., Gorischek C.et al. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de nove acute myeloid leukemia. Blood. 77:1991;700-711.
15. Kita K., Nishii K., Oishi K., Morita N., Takakura N., Kawakami K.et al. Frequent gene expression of granulocyte colony-stimulating factor (G-CSF) receptor in CD7+ surface CD3-acute lymphoblastic leukemia. Leukemia. 7:1993;1184-1190.
16. Nicklee T., Crump M., Hedley D.W. Effects of topoisomerase I inhibition on the expression of topoisomerase IIα measured with fluorescence image cytometry. Cytometry. 25:1996;205-210.
17. Tsurusawa M., Aoyama M., Saeki K., Fujimoto T. Cell cycle kinetics in childhood acute leukemia studied with in vitro bromodeoxyuridine labeling, Ki67-reactivity, and flow cytometry. Leukemia. 9:1995;1921-1925.
18. Michieli M., Damiani D., Ermacora A., Raspadori D., Michelutti A., Grimaz S.et al. P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells. Br. J. Haematol. 96:1997;356-365.
19. Pui C.H., Hancock M.L., Head D.R., Rivera G.K., Look A.T., Sandlund J.T.et al. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood. 82:1993;889-894.
20. Borowitz M.J., Shuster J.J., Civin C.I., Carroll A.J., Look A.T., Behm F.G.et al. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study. J. Clin. Oncol. 8:1990;1389-1398.
21. Cascavilla N., Musto P., D'Arena G., Ladogana S., Matera R., Carotenuto M. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression. Haematologica. 82:1997;31-37.
22. Chaudhary P.M., Mechetner E.B., Roninson I.B. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood. 80:1992;2735-2739.
23. Nooter K., Burger H., Stoter G. Multidrug resistance-associated protein (MRP) in haematological malignancies. Leuk. Lymph. 20:1996;381-387.
24. Reuss-Borst M.A., Klein G., Waller H.D., Muller C.A. Differential expression of adhesion molecules in acute leukemia. Leukemia. 9:1995;869-874.
25. Mustjoki S., Alitalo R., Elonen E., Carpen O., Gahmberg C.G., Vaheri A. Intercellular adhesion molecule-1 in extravasation of normal mononuclear and leukaemia cells. Br. J. Haematol. 113:2001;989-1000.
26. Mengarelli A., Zarcone D., Caruso R., Tenca C., Rana I., Pinto R.M.et al. Adhesion molecule expression, clinical features and therapy outcome in childhood acute lymphoblastic leukemia. Leuk. Lymph. 40:2001;625-630.
27. Shibata S., Asano Y., Yokoyama T., Shimoda K., Nakashima H., Okamura S.et al. Analysis of the granulocyte colony-stimulating factor receptor gene structure using PCR-SSCP in myeloid leukemia and myelodysplastic syndrome. Eur. J. Haematol. 60:1998;197-201.
28. Nicklee T., Crump M., Hedley D.W. Effects of topoisomerase I inhibition on the expression of topoisomerase II alpha measured with fluorescence image cytometry. Cytometry. 25:1996;205-210.
29. Schwonzen M., Kuehn N., Vetten B., Diehl V., Pfreundschuh M. Phenotyping of acute myelomonocytic (AMMOL) and monocytic leukemia (AMOL): association of T-cell-related antigens and skin-infiltration in AMOL. Leuk. Res. 13:1989;893-898.
30. Weiss M.A., Warrell R.P. Jr. Two cases of extramedullary acute promyelocytic leukemia. Cytogenetics, molecular biology, and phenotypic and clinical studies. Cancer. 74:1994;1882-1886.
31. Nagao K., Kikuchi A., Kawai Y., Kizaki M., Ikeda Y., Nishikawa T. Skin infiltration in acute promyelocytic leukemia. Dermatology. 194:1997;168-171.